Gastric Cancer Therapy Market to Grow with a CAGR of 6.13% through 2028
Rising
prevalence of gastric cancer are expected to drive the Global Gastric Cancer
Therapy Market in the forecast period 2024-2028.
According to
TechSci Research report, “Gastric Cancer Therapy Market – Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2028”,
the Global Gastric Cancer Therapy Market stood at USD 3.51 billion in 2022 and
is anticipated to grow with a CAGR of 6.13% in the forecast period, 2024-2028.
The increasing prevalence of melanoma cases worldwide is a key driver of the
market. The increasing prevalence of gastric cancer and the introduction of
innovative treatments for advanced cancer are notable trends. For example,
based on the 2022 data presented by the American Cancer Society, approximately
26,380 fresh instances of gastric cancer (15,900 in males and 10,480 in
females) are projected to be identified in the United States this year.
Furthermore, as outlined in a publication by the American Society of Clinical
Oncology Journal in July 2020, titled "Cancer Statistics, 2020: Report
from National Cancer Registry Programme, India," it was discovered that in
India, 50.8% of patients were diagnosed at the locally advanced stage of
stomach cancer. Consequently, the growing prevalence of stomach cancer in the
population is projected to enhance the demand for effective treatments and
therapies, thereby stimulating the growth of global gastric cancer therapy market.
Gastric cancer,
also known as stomach cancer, is a malignant tumor that originates in the
lining of the stomach. It is a type of gastrointestinal cancer and typically
develops over a period of time, often without causing noticeable symptoms in
its early stages. Gastric cancer can be categorized into several subtypes, each
with distinct characteristics and treatment implications. Symptoms of gastric
cancer can include indigestion, persistent abdominal discomfort or pain,
unintentional weight loss, nausea, vomiting, and a feeling of fullness even
after consuming a small amount of food. In advanced stages, symptoms may
include blood in the stool, fatigue, and jaundice. Diagnosis involves a
combination of imaging tests (such as endoscopy, CT scans, and PET scans),
biopsies, and molecular testing to determine the extent of the disease and its
characteristics. Treatment options for gastric cancer depend on factors like the
stage of cancer, the patient's overall health, and the tumor's molecular
profile. Treatment can include surgery, chemotherapy, radiation therapy,
targeted therapy, immunotherapy, and palliative care. Early detection is
crucial for successful treatment outcomes, and efforts are being made to
improve diagnostic methods and raise awareness about risk factors. Advances in
research and technology are continually shaping the field of gastric cancer
therapy, offering hope for improved treatment strategies and better patient
outcomes.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "Global
Gastric Cancer Therapy Market”
The drivers of
the global Gastric Cancer Therapy Market are multifaceted and dynamic,
propelling its growth and evolution. The foremost driver is the escalating
global incidence of gastric cancer, necessitating effective treatment
solutions. Advances in therapeutic approaches, particularly the emergence of
immunotherapies and precision medicine, are reshaping treatment paradigms and
improving patient outcomes.
Increasing
emphasis on early detection through awareness campaigns and improved diagnostic
technologies contributes to more favorable treatment outcomes. Collaborative
research and development efforts among pharmaceutical companies, research
institutions, and healthcare organizations yield innovative therapies and
regimens. The aging global population intensifies the demand for tailored
therapies, as the elderly are at higher risk of gastric cancer. The increasing
prevalence of gastric cancer globally, particularly in regions with high-risk
factors like certain dietary habits and infections, drives the demand for
effective therapies and treatments. The introduction of innovative treatment
options, including immunotherapies and targeted therapies, is reshaping the
treatment landscape. These novel approaches offer improved efficacy and better
outcomes for patients. The evolution of personalized medicine, guided by
genetic and molecular profiling, enables tailored treatment strategies. This
individualized approach enhances treatment effectiveness while minimizing side
effects. Public awareness initiatives
increase understanding of risk factors, symptoms, and the importance of regular
screenings, leading to early diagnosis and better patient outcomes. The synergy
between healthcare providers, pharmaceutical companies, research institutions,
and patient advocacy groups accelerates the translation of research findings
into clinical practice. These drivers collectively fuel the expansion of the
Gastric Cancer Therapy Market, ensuring that patient care evolves with the
integration of cutting-edge therapies, improved early detection, and increased
awareness.
The Global
Gastric Cancer Therapy Market is segmented into therapy type, end user, regional
distribution, and company.
Based on therapy
type, the market is segmented into Chemotherapy, Targeted Therapy,
Immunotherapy. The Targeted Therapy is expected to rise in the forecast period.
This is attribute due to its precision
in attacking specific molecular targets on cancer cells, minimizing harm to
healthy tissue. Unlike chemotherapy with broader effects, targeted therapies
offer higher efficacy and reduced side effects. Immunotherapy harnesses the
immune system but may not work for all patients. Targeted therapies often have higher
response rates due to their tailored approach. As a result, they are becoming
the preferred choice for many patients and healthcare professionals,
positioning them as a dominant force in the treatment landscape.
Based on end
user, the market is segmented into Ambulatory Surgery Centers, Hospitals and
Specialty Clinics, and Other. The Hospitals and Specialty Clinics segment was
dominated the market in 2022. This is due to their comprehensive
infrastructure, resources, and ability to handle diverse medical needs. They
provide a wide range of services under one roof, including advanced
diagnostics, surgery, and post-operative care. Additionally, hospitals offer a
multidisciplinary approach, facilitating collaboration among specialists. In
contrast, ambulatory surgery centers (ASCs) focus primarily on same-day
surgical procedures, limiting their scope. While ASCs offer convenience and
cost-effectiveness, the complexity and variety of cases treated at hospitals
and specialty clinics make them the preferred choice for patients requiring
comprehensive care, contributing to their dominance in the healthcare
landscape.
Major companies operating
in Global Gastric Cancer Therapy Market are:
- Abbott Laboratories Inc.
- Amgen, Inc.
- Celltrion
Inc.
- Novartis
AG
- F.
Hoffmann-La Roche Ltd
- Agilent
Technologies Inc.
- AstraZeneca Plc
- Pfizer Inc.
- Eli Lilly & Co.
- GlaxoSmithKline Plc
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“The increasing
incidence of gastric cancer worldwide, necessitating effective treatment
solutions. Advances in therapeutic approaches, particularly the emergence of
immunotherapies and precision medicine, are revolutionizing treatment paradigms
and improving patient outcomes. Additionally, Collaborative research and
development efforts among pharmaceutical companies, research institutions, and
healthcare organizations are yielding innovative therapies and treatment
regimens. The aging global population is intensifying the demand for
personalized therapies, as the elderly are at higher risk of developing gastric
cancer. Government support, favorable regulatory environments, and a growing
focus on healthcare infrastructure development are contributes to foster the
demand for Global Gastric Cancer Therapy Market in the forecast period” said
Mr. Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“Gastric
Cancer Therapy Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2018-2028 Segmented By Therapy Type (Chemotherapy, Targeted Therapy,
Immunotherapy, Radiation Therapy, and Surgery), By End User (Ambulatory Surgery
Centers, Hospitals and Specialty Clinics, and Other), By Region and Competition” has
evaluated the future growth potential of Global Gastric Cancer Therapy Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Gastric Cancer Therapy Market.
Contact
Techsci Research LLC
420 Lexington Avenue
Suite 300, New York
United States- 10170
M: +13322586602
Email: [email protected]
Web: https://www.techsciresearch.com